BACKGROUND: We sought to investigate the impact of the COVID-19 pandemic and the Tele-HF Clinic (Tele-HFC) program on cardiovascular death, heart failure (HF) rehospitalization, and heart transplantation rates in a cohort of ambulatory HF patients during and after the peak of the pandemic. METHODS: Using the HF clinic database, we compared data of patients with HF before, during, and after the peak of the pandemic (January 1 to March 17 [pre-COVID], March 17 to May 31 [peak-COVID], and June 1 to October 1 [post-COVID]). During peak-COVID, all patients were managed by Tele-HFC or hospitalization. After June 1, patients chose either a face-to-face clinic visit or a continuous tele-clinic visit. RESULTS: Cardiovascular death and medical titration rates were similar in peak-COVID compared with all other periods. HF readmission rates were significantly lower in peak-COVID (8.7% vs. 2.5%, p<0.001) and slightly increased (3.5%) post-COVID. Heart transplant rates were substantially increased in post-COVID (4.5% vs. peak-COVID [0%], p = 0.002). After June 1, 38% of patients continued with the Tele-HFC program. Patients managed by the Tele-HFC program for <6 months were less likely to have HF with reduced ejection fraction (73% vs. 54%, p = 0.005) and stage-D HF (33% vs. 14%, p = 0.001), and more likely to achieve the target neurohormonal blockade dose (p<0.01), compared with the ≥6-month Tele-HFC group. CONCLUSIONS: HF rehospitalization and transplant rates significantly declined during the pandemic in ambulatory care of HF. However, reduction in these rates did not affect subsequent 5-month hospitalization and cardiovascular mortality in the setting of Tele-HFC program and continuum of advanced HF therapies.
BACKGROUND: We sought to investigate the impact of the COVID-19 pandemic and the Tele-HF Clinic (Tele-HFC) program on cardiovascular death, heart failure (HF) rehospitalization, and heart transplantation rates in a cohort of ambulatory HF patients during and after the peak of the pandemic. METHODS: Using the HF clinic database, we compared data of patients with HF before, during, and after the peak of the pandemic (January 1 to March 17 [pre-COVID], March 17 to May 31 [peak-COVID], and June 1 to October 1 [post-COVID]). During peak-COVID, all patients were managed by Tele-HFC or hospitalization. After June 1, patients chose either a face-to-face clinic visit or a continuous tele-clinic visit. RESULTS:Cardiovascular death and medical titration rates were similar in peak-COVID compared with all other periods. HF readmission rates were significantly lower in peak-COVID (8.7% vs. 2.5%, p<0.001) and slightly increased (3.5%) post-COVID. Heart transplant rates were substantially increased in post-COVID (4.5% vs. peak-COVID [0%], p = 0.002). After June 1, 38% of patients continued with the Tele-HFC program. Patients managed by the Tele-HFC program for <6 months were less likely to have HF with reduced ejection fraction (73% vs. 54%, p = 0.005) and stage-D HF (33% vs. 14%, p = 0.001), and more likely to achieve the target neurohormonal blockade dose (p<0.01), compared with the ≥6-month Tele-HFC group. CONCLUSIONS: HF rehospitalization and transplant rates significantly declined during the pandemic in ambulatory care of HF. However, reduction in these rates did not affect subsequent 5-month hospitalization and cardiovascular mortality in the setting of Tele-HFC program and continuum of advanced HF therapies.
Authors: Josiane J J Boyne; Hubertus J M Vrijhoef; Harry J G M Crijns; Gerjan De Weerd; Johannes Kragten; Anton P M Gorgels Journal: Eur J Heart Fail Date: 2012-05-15 Impact factor: 15.534
Authors: Friedrich Koehler; Sebastian Winkler; Michael Schieber; Udo Sechtem; Karl Stangl; Michael Böhm; Herbert Boll; Gert Baumann; Marcus Honold; Kerstin Koehler; Goetz Gelbrich; Bridget-Anne Kirwan; Stefan D Anker Journal: Circulation Date: 2011-03-28 Impact factor: 29.690
Authors: Sarwat I Chaudhry; Christopher O Phillips; Simon S Stewart; Barbara Riegel; Jennifer A Mattera; Anthony F Jerant; Harlan M Krumholz Journal: J Card Fail Date: 2007-02 Impact factor: 5.712
Authors: William Claiborne Dunagan; Benjamin Littenberg; Gregory A Ewald; Catherine A Jones; Valerie Beckham Emery; Brian M Waterman; Daniel C Silverman; Joseph G Rogers Journal: J Card Fail Date: 2005-06 Impact factor: 5.712
Authors: Maria Ansari; Michael G Shlipak; Paul A Heidenreich; Denise Van Ostaeyen; Elizabeth C Pohl; Warren S Browner; Barry M Massie Journal: Circulation Date: 2003-05-19 Impact factor: 29.690
Authors: Kevin J Clerkin; Justin A Fried; Jayant Raikhelkar; Gabriel Sayer; Jan M Griffin; Amirali Masoumi; Sneha S Jain; Daniel Burkhoff; Deepa Kumaraiah; LeRoy Rabbani; Allan Schwartz; Nir Uriel Journal: Circulation Date: 2020-03-21 Impact factor: 29.690
Authors: Eiran Z Gorodeski; Parag Goyal; Zachary L Cox; Jennifer T Thibodeau; Rebecca E Reay; Kismet Rasmusson; Joseph G Rogers; Randall C Starling Journal: J Card Fail Date: 2020-04-18 Impact factor: 5.712
Authors: Daniel I Bromage; Antonio Cannatà; Irfan A Rind; Caterina Gregorio; Susan Piper; Ajay M Shah; Theresa A McDonagh Journal: Eur J Heart Fail Date: 2020-07-04 Impact factor: 17.349
Authors: Shih-An Liu; Chieh-Liang Wu; I-Ju Chou; Pa-Chun Wang; Chia-Ling Hsu; Chia-Pei Chen Journal: Int J Environ Res Public Health Date: 2022-02-17 Impact factor: 3.390